FDA Adverse Event Injury Summary report: N

UNKNOWN DEPUY ASR CUP

MDR report key: 2892723 · Received January 2, 2013

Report

Report Number
1818910-2013-00551
Event Type
Injury
Date Received
January 2, 2013
Date of Event
September 5, 2012
Report Date
December 12, 2012
Manufacturer
DEPUY INTERNATIONAL
Product Code
KWA
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WA, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

(B)(4). LITIGATION ALLEGES PATIENT HAD PAIN, STIFFNESS, DISCOMFORT AND WEAKNESS WHICH NEGATIVELY AFFECT MOBILITY; TOXICITY OF METAL IN THE BODY; AND THE ABILITY TO PERFORM NORMAL PHYSICAL ACTIVITIES IS LIMITED AFTER ASR HIP IMPLANT. REVISION SURGERY FOUND SOME GRAYISH TISSUE IN THE SYNOVIUM AND THAT THE ACETABULAR COMPONENT HAD MINIMAL BONE GROWTH. DEPUY STILL CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Description of Event or Problem · 1

PATIENT CONTACTED DEPUY AS A RESULT OF THE ASR RECALL TO INITIATE A CLAIM. MEDICAL RECORDS WERE OBTAINED. MEDICAL RECORDS INDICATE THAT THE PATIENT WAS REVISED TO ADDRESS DISCOMFORT AND GROIN PAIN AND INCREASED COBALT AND CHROMIUM LEVELS. NOTED WAS LITTLE BONE INGROWTH OF THE ACETABULAR COMPONENT AND GRAY SYNOVIAL TISSUE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1757 UNKNOWN DEPUY ASR CUP CUP KWA DEPUY INTERNATIONAL UNK

Patients

Seq Age Sex Outcome Treatment
1 66 YR Required Intervention